Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
CRMD
#2456
CorMedix Inc.
7.130
0
-1.79%
Secteur:
Base:
Devise de Profit:
Range quotidien
Range Annuel
Changement quotidien
-1.79%
Changement Mensuel
-8.24%
Evolution sur 6 mois
-36.90%
Changement Annuel
-36.90%
Clôture Précédente
7.260
0
Open
7.130
0
Bid
Ask
Low
7.130
0
High
7.130
0
Volume
99
Marchés
Actions des Marchés US
Soins de Santé
CRMD
Open full chart
Financials
Overview
Relevé
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
38.02 M
38.73 M
44.5 M
54.98 M
65.18 M
—
Valuation ratios
Enterprise value
240.61 M
122.9 M
142.86 M
163.64 M
487.32 M
2.47 B
Price to earnings ratio
—
-0.02
-5.65
-4.14
-27
19
Price to sales ratio
—
2.27
2 573.79
—
10.97
26.44
Price to cash flow ratio
—
-0.02
-6.91
-5
-9.42
13.81
Price to book ratio
—
0.01
3.06
2.74
5.63
9.71
Enterprise value to EBITDA ratio
-8.88
-4.18
-4.68
-3.35
-22.1
24.24
Profitability ratios
Return on assets %
-0.45
-0.41
-0.48
0.56
-0.15
0.47
Return on equity %
-0.5
-0.45
-0.54
0.66
-0.21
0.72
Return on invested capital %
-12.93 K
-5 882.72
-4 602.58
-7 277.18
-457.82
812.79
Gross margin %
14.37
22
94.29
—
92.66
376.73
Operating margin %
-11.38 K
-15.42 K
-46.82 K
—
-51.43
191.37
EBITDA margin %
-11.32 K
-15.39 K
-46.69 K
—
-50.71
200.13
Net margin %
-9 207.7
-14.77 K
-45.41 K
—
-41.24
249.97
Liquidity ratios
Quick ratio
11.54
12.43
9.44
6.78
3.16
16.4
Current ratio
11.58
12.44
9.44
6.97
3.39
17.36
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.01
0
0
0
0.43
1.01
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
-222.02
-0.6
-0.75
-0.86
0.97
EBIT per share
—
-308.94
-0.76
-0.96
-0.38
1.42
EBITDA per share
—
-308.29
-0.76
-0.96
-0.37
1.47
Total debt per share
—
—
—
—
—
—
Cash per share
—
687.05
1.46
1.49
0.88
5.3
Net current asset value per share
—
697.57
1.48
1.56
1.95
10.51
Tangible book value per share
—
659.05
1.37
1.38
1.41
5.7
Working capital per share
—
641.48
1.32
1.34
1.37
7.44
Book value per share
—
659.05
1.37
1.38
1.44
10.51
Nouvelles
Cytek Biosciences, Inc. (CTKB) Reports Q4 Loss, Tops Revenue Estimates
CRMD vs. TBPH: Which Small-Cap Biotech Stock Is the Better Bet?
Should Investors Buy, Sell or Hold CRMD Stock Ahead of Q4 Earnings?
CorMedix Down 27% in 3 Months: Is It Time to Sell the Stock?
CorMedix Inc. (CRMD) Analyst/Investor Day Transcript
CorMedix Inc. (CRMD) Analyst/Investor Day - Slideshow (NASDAQ:CRMD) 2026-02-11
Citizens réitère sa note Surperformance du marché pour l’action CorMedix
CorMedix Banks on DefenCath Sales in Q4 as Melinta Adds Upside
L’action CorMedix grimpe après l’annonce d’un plan de rachat d’actions de 75 millions $
CorMedix stock rises after announcing $75 million share buyback plan
CorMedix annonce un programme de rachat d’actions de 75 millions $
CorMedix announces $75 million share repurchase program